Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Galmed Pharmaceutica (GLMD)

6.31 +0.30 (+4.99%)

6/26/2017  2:47pm

Open:

6.27

Pre. Close:

6.01

High:

6.58

Low:

6.19

Volume:

20,835

Market Cap:

76.78M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.3 - 6.37

6.37 - 6.45

Low:

5.51 - 5.61

5.61 - 5.73

Close:

5.8 - 5.96

5.96 - 6.16

Technical analysis  (as of: 2017-06-26 2:29:55 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 8.55     One year: 9.99

Support:

Support1: 5.71    Support2: 4.71

Resistance:

Resistance1: 7.32    Resistance2: 8.55

Pivot:

5.77

Moving Averages:

MA(5): 6.15     MA(20): 5.57

MA(100): 4.94     MA(250): 4.35

MACD:

MACD(12,26): 0.35     Signal(12,26,9): 0.30

%K %D:

%K(14,3): 50.32     %D(3): 52.75

RSI:

RSI(14): 60.45

52-Week:

High: 7.32  Low: 2.78  Change(%): 29.8

Average Vol(K):

3-Month: 34  10-Days 55

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GLMD has closed below upper band by 35.2%. Bollinger Bands are 228.7% wider than normal. The large width of the bands suggest high volatility as compared to GLMD's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Thu, 08 Jun 2017 10:52:30 GMT
Galmed Pharmaceuticals Announces the Election of Dr. Carol L. Brosgart as a ...

Thu, 28 Jul 2016 12:03:10 GMT
Galmed Pharmaceuticals and SAMIL Pharm Sign a License Agreement for the ...

Thu, 08 Sep 2016 12:33:13 GMT
Galmed Pharmaceuticals Announces the Appointment of Dr. Liat Hayardeny, Ph.D ...

Thu, 16 Mar 2017 12:33:45 GMT
Galmed Pharmaceuticals Fourth Quarter 2016 Conference Call and Webcast ...

Mon, 09 Jan 2017 12:56:15 GMT
Galmed Pharmaceuticals Completes Patient Recruitment for ARREST Phase IIb NASH ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

12.17

Shares Float (M)

7.44

% Held by Insiders

% Held by Institutions

Shares Short (K)

124

Shares Short Prior Month (K)

125

Stock Financials

EPS

-1.390

EPS Est. Current Year

-1.040

EPS Est. Next Year

-1.350

EPS Est. Next Quarter

-0.270

Forward EPS

-1.349

Book Value (p.s.)

0.680

PEG Ratio

Profit Margin

Operating Margin

-2182.72

Return on Assets (ttm)

-59.4

Return on Equity (ttm)

-123.2

Qtrly Rev. Growth

Gross Profit (p.s.)

0.038

Sales Per Share

EBITDA (p.s.)

-1.302

Qtrly Earnings Growth

Operating Cash Flow (M)

-12.92

Levered Free Cash Flow (M)

-7.41

FoxReading.com

Valuation

P/E

-4.45

P/E Growth Ratio

0.03

P/BV

9.10

P/S

1255538304.00

P/CF

-5.83

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.